Form 8-K - Current report:
SEC Accession No. 0001628280-25-003073
Filing Date
2025-01-30
Accepted
2025-01-30 07:51:27
Documents
14
Period of Report
2025-01-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K vir-20250124.htm   iXBRL 8-K 23647
  Complete submission text file 0001628280-25-003073.txt   181522

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vir-20250124.xsd EX-101.SCH 2139
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vir-20250124_def.xml EX-101.DEF 15302
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vir-20250124_lab.xml EX-101.LAB 26870
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vir-20250124_pre.xml EX-101.PRE 16021
16 EXTRACTED XBRL INSTANCE DOCUMENT vir-20250124_htm.xml XML 3339
Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39083 | Film No.: 25571196
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)